| Title | Deciding on the best treatment strategy for recurrent febrile seizures: an evidence-based medicine approach | ||
| Authors | Ch. Sardeli1, Th. Tzellos1, E. Amaniti2, G. Papazisis1, K. Karakoulas2, Ch. Pourzitaki1 and D. Kouvelas1
1. Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Greece and 2. Anesthesiology Clinic and ICU, School of Medicine, Aristotle University of Thessaloniki, Greece |
||
| Citation | Sardeli, C., Tzellos, T., Amaniti, E., Papazisis, G., Karakoulas, K. et al.: Deciding on the best treatment strategy for recurrent febrile seizures: an evidence-based medicine approach, Epitheorese Klin. Farmakol. Farmakokinet. 22(2): 320-321 (2008) | ||
| Publication Date | 23-25 May 2008 | ||
| Full Text Language | English | ||
| Order – Buy | Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)
pharmakonpress[at]pharmakonpress[.]gr |
||
| Keywords | Recurrent complex febrile seizures, anticonvulsive drugs, intermittent diazepam, evidence-based medicine. | ||
| Other Terms | Review article | ||
| Summary | Febrile seizures are the most prevalent type of seizures in children aged 0-5 years, often recurring in 20-30% of the cases. In daily clinical practice, complex febrile seizures mandate administration of anticonvulsive drugs. Evidence regarding the need to initiate anticonvulsive therapy for the prevention of re-current CFS (rCFS) and what the appropriate choice of treatment should be remains controversial. Decision making depends solely on physician experience and personal preference and opinion. In order to efficiently integrate valid information and provide a basis for rational decision making, the literature was systematically reviewed to determine the best treatment strategy. | ||
| References | 1. American Academy of Pediatrics: Practice parameter: the neurodiagnostic evaluation of the child with a first simple febrile seizure. Pediatrics 97: 769-775 (1996)
2. Nelson K.B., Ellenberg J.H.: Prognosis in children with febrile seizures. Pediatrics 61: 720-727 (1978) 3. Rosman N.P., Colton T., Labazzo J., Gilbert P.L., Gardella N.B., Kaye E.M., Van Bennekom C., Winter M.R.: A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. N. Engl. J. Med. 329: 79-84 (1993) 4. Thilothammal N., Kannan, Krishnamurthy P.V., Kamala K.G., Ahamed S., Banu K.: Role of phenobarbitone in preventing recurrence of febrile convulsions. Indian Pediatrics 30: 637-642 (1993) 5. Knudsen F.U., Paerregaard A., Andersen R., Andresen J.: Long term outcome of prophylaxis for febrile convulsions. Arch. Dis. Child 74: 13-18 (1996) 6. Rantala H., Tarkka R., Uhari M.: A meta-analytic review of the preventive treatment of recurrences of febrile seizures. J. Pediatr 151: 922-925 (1997) 7. Masuko A.H., Castro A.A., Santos G.R., Atallah A.N., do Prado L.B., de Carvalho L.B., do Prado G.F.: Intermittent diazepam and continuous phenobarbital to treat recurrence of febrile seizures. Arq. Neuropsiquiatr. 61: 897-901 (2003) 8. Rose W., Kirubakaran C., Scott J.X.: Intermittent clobazam therapy in febrile seizures. Indian J. Pediatr. 72: 31-33 (2005) 9. Pavlidou E., Tzitiridou M., Panteliadis C.: Effectiveness of intermittent diazepam prophylaxis in febrile seizures: long-term prospective controlled study. J. Child. Neurol. 21: 1036-1040 (2006) 10. Pavlidou E., Tzitiridou M., Ramantani G., Panteliadis C.: Indications for intermittent diazepam prophylaxis in febrile seizures. Klin. Padiatr. 218: 264-269 (2006) |
||
| Relative Papers | |||
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
- Chemical Abstracts
- Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Συντακτικη Επιτροπή-Editorial Board
| ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2008 – ANNUAL SUBSCRIPTION 2008 | |
| Γλώσσα Πλήρους Κειμένου – Full Text Language | Αγγλικά – English |
| Παραγγελία – Αγορά – Order – Buy | Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr |
| Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr |
|